(Q37669172)

21 August 2017

1 reference

title

Antifibrotic therapies--emerging biomarkers as treatment end points (English)

1 reference

21 August 2017

0 references

Jayant A Talwalkar

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

21 August 2017

published in

1 reference

21 August 2017

volume

7

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

59-61

1 reference

Advances in antifibrotic therapy

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Liver biopsy: The best, not the gold standard

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Diagnosis and quantitation of fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Non-invasive evaluation of liver fibrosis using transient elastography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Assessment of hepatic fibrosis with magnetic resonance elastography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Elastography for the non-invasive assessment of liver disease: limitations and future developments.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Circulating endothelial cells in oncology: pitfalls and promises

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Circulating endothelial cells in cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Angiogenesis in liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

In vivo detection of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.197

Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20051972

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20051972

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2009.197

1 reference

21 August 2017

1 reference